COVID-19 | FDAnews

Takeda to Develop Coronavirus Treatment

March 12, 2020

Plasma derived-therapies have previously been shown effective for treating viral respiratory infections. Read More

HHS Requests Development Plans for COVID-19 Diagnostics

March 10, 2020

The agency is most interested in products that have progressed beyond non-clinical studies. Read More

Quest Launches COVID-19 Test Service

March 9, 2020

The new service will test respiratory specimens collected in hospitals and physician offices. Read More

Elitech Earns CE Mark for COVID-19 Diagnostic

March 5, 2020

The test kit confirms the quality of the extracted sample material. Read More

Coronavirus R&D Gets $3.1 Billion in Emergency Funding

March 5, 2020

The bill allocated approximately $500 million for procurement of masks, personal protective equipment, pharmaceuticals and other medical supplies. Read More

FDA Issues New Policy to Expedite Coronavirus Diagnostics

March 2, 2020

FDA Commissioner Stephen Hahn said the agency is “adapting to this dynamic and evolving situation.” Read More

No Device Shortages from COVID-19 Outbreak, FDA Says

February 28, 2020

FDA Commissioner Stephen Hahn said that several facilities have been adversely affected by the outbreak. Read More

Co-Diagnostics’ Coronavirus Test Earns CE Mark

February 25, 2020

“We believe Co-Diagnostics is the first U.S. company to receive a CE-marking for a coronavirus IVD,” the company’s CEO said. Read More

CDC Issues New Coronavirus Test Reagents

February 24, 2020

The CDC also reported increased demand for respirators and facemasks. Read More

Novacyt Nabs CE Mark for COVID-19 Diagnostic

February 19, 2020

The company previously launched a research-use-only test for the novel coronavirus on January 31. Read More

IMDRF Cancels Singapore Meetings Because of COVID-19 Outbreak

February 18, 2020

The number of confirmed cases of COVID-19 infection in Singapore was 77 as of February 17. Read More

Coronavirus Outbreak Threatens Supply Chain, Says Former FDA Commissioner

February 14, 2020

It may be harder to identify and mitigate potential shortages for devices, he said. Read More

COVID-19
RSS

Takeda to Develop Coronavirus Treatment

HHS Requests Development Plans for COVID-19 Diagnostics

Quest Launches COVID-19 Test Service

Elitech Earns CE Mark for COVID-19 Diagnostic

Coronavirus R&D Gets $3.1 Billion in Emergency Funding

FDA Issues New Policy to Expedite Coronavirus Diagnostics

No Device Shortages from COVID-19 Outbreak, FDA Says

Co-Diagnostics’ Coronavirus Test Earns CE Mark

CDC Issues New Coronavirus Test Reagents

Novacyt Nabs CE Mark for COVID-19 Diagnostic

IMDRF Cancels Singapore Meetings Because of COVID-19 Outbreak

Coronavirus Outbreak Threatens Supply Chain, Says Former FDA Commissioner

Upcoming Events

FDA Ad and Promo Enforcement Trends: Past, Present and Future

EU-MDR’s Growing Pains: Are You Current with the Latest Developments?

Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does

Medical Device Cybersecurity: Understand the Latest Developments

Pharmaceutical Process Validation: Best Practices for Success

Gene & Cell Therapy Regulation: Comparability and Other New Developments

Featured Products

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

FDA Provides Update on GE Healthcare’s Recall of Its Carescape R860 Ventilators

Gilead Resubmits NDA for Lenacapavir Following Complete Response Letter

FDA Warns Baby Neck Floats Used in Water Therapy Can Cause Death or Injury

U.S. Government Inks $3.2 Billion Contract With Pfizer-BioNTech for Vaccine Booster Campaign

The Revised ICH E8: A Guide to New Clinical Trial Requirements

COVID-19 RSS

The Revised ICH E8: A Guide to New Clinical Trial Requirements

COVID-19
RSS